Sign in
4

Changes in Ownership

PDS Biotechnology Corp Filed Acc 0001127602-18-021574

Options or other derivatives

  • President and CEO acquired 338,068 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Leuthner Brian A · President and CEO

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2018-06-19 Grant or award : show line 1 in the form Stock Option (Right To Purchase) +338,068 338,068 D
Loading xslF345X03/form4.xml…